1000 Pediatric Kidney Transplants-A Single Center Experience
Surg, U Mn, Mpls, MN
Ped Nephrol, U Mn, Mpls
Meeting: 2013 American Transplant Congress
Abstract number: C1419
Objective: To study outcomes and risk-factors for graft-loss in > 1000 pediatric kidney transplants.
Methods: We studied outcomes by immunosuppression era: I) 1963-83 (ATG, Imuran and steroids); II) 1984-2001 (introduction of CNIs); and III) 2001-present (steroid avoidance).
Results: 1010 transplants (Age<1yr=53, 1-2yr=124, 3-5yr=182, 6-10yr=216, 11-18=435) were done. (810 Ist; 200 retx) (LD=69%, DD=31%; 3% LURDs pre-2001, 17% since [p<.01]). Congenital-anomalies were the commonest indication (Table 1) Ten-yr actuarial patient-survival (p <0.001), graft survival (p=0.0005), and death-censored graft-survival (p=.02) steadily improved by era (Table 1). Graft half-life (starting @ 1 yr posttx) is 33 years for LDs, 14 years for DDs. Graft-loss for all causes < 1 year posttx has ⇓ by era (Table 1); from 1-5 yrs, CR/IFTA remains predominant. For the entire cohort, by multivariate-analysis, LD(p<.0001) and Era III (vs I and II) (p<.0003) had better survival.↑ LD donor age did not affect graft survival.Risk-factors for loss varied by era (Table 2). Successful transplant was associated with improved QoL, and return-to-school and (subsequently) work.
Conclusions: Long term Outcomes of pediatric renal transplantation have continued to improve. LD grafts provide the most benefit and should be the first option.
| Era I 1963-1983 (n=362) | Era II 1984-2001 (n=451) | Era III 2001-2012 (n=197) | |
| Indication for Transplant | |||
| Congenital Anomalies | 60(17%) | 95(21%) | 52(26%) | 
| Obstructive Nephropathy | 52(15%) | 81(18%) | 28(20%) | 
| Congenital Nephrotic Syndrome | 34(9.4%) | 36(8%) | 9(5%) | 
| FSGS Steriod Resistan | 23(6%) | 35(7%) | 23(11%) | 
| GN-CGN | 53(15%) | 7(1.5%) | 0 | 
| 10-Year Patient Survival (%) | |||
| LD | 76 | 92 | 94 | 
| DD | 66 | 94 | 100 | 
| 10-Year Graft Survival (%) | |||
| LD | 49 | 65 | 75 | 
| DD | 31 | 43 | 57 | 
| Causes of Graft Loss < 1 Year (%) | |||
| Acute Rejection | 8 | 2 | 0.6 | 
| Chronic Rejection/CAN | 5 | 1 | 0.6 | 
| Recurrence | 2 | 2 | 1 | 
| Technical/Thrombosis | 3 | 4 | 2 | 
| DWF | 5 | 1 | 1 | 
| Functioning | 75 | 88 | 95 | 
| Causes of Graft Loss 1-5 Years (%) | |||
| Acute Rejection | 0.7 | 0.8 | 2 | 
| Chronic Rejection/CAN | 14 | 10 | 6 | 
| Recurrence | 2 | 2 | 1 | 
| Non Compliance | 0.4 | 2 | 2 | 
| DWF | 6 | 1 | 2 | 
